GlassScriptPhysician profile
Michel M Mcdonough
NPI 1083652879
$4,585.87
in general payments reported to CMS, 2019-2025
42 companies · $685 in 2025
The $685 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $645 · 2020: $218 · 2021: $426 · 2022: $1,097 · 2023: $878 · 2024: $636 · 2025: $685.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,000 · Education: $199.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,000.28 |
| Education | $198.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $884.88 | 2019-2024 | |
| Astellas Pharma US INC | $583.53 | 2019-2025 | Veozah, Myrbetriq |
| Novo Nordisk INC | $457.16 | 2019-2025 | Wegovy |
| Mayne Pharma Commercial LLC | $327.34 | 2021-2025 | |
| Exeltis, USA INC. | $296.95 | 2021-2025 | Slynd |
| Shield Therapeutics INC | $294.24 | 2022-2024 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $223.07 | 2019-2023 | |
| Allergan, INC. | $161.96 | 2019-2020 | |
| Pfizer INC. | $147.71 | 2019-2025 | |
| Medtronic, INC. | $113.59 | 2022-2024 | Plasmablade(Tm) |
| Intuitive Surgical, INC. | $89.01 | 2020-2022 | |
| Aspira Women'S Health INC | $79.92 | 2023 | Ova1 |
| Daiichi Sankyo INC. | $76.26 | 2022-2023 | Injectafer |
| Roche Diagnostics Corporation | $70.21 | 2019 | |
| Organon LLC | $69.52 | 2021-2025 | Nexplanon |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michel Mcdonough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.